Insomnia

>

The NeurologyLive® Insomnia Disease Spotlight page offers specific updates and coverage on the latest expert conversations and data readouts related to the treatment and management of patients with the disorder of sleepiness.

Latest News

In-hwan Baek, PhD, professor of pharmacy at Kyungsung University
Meta-Analysis Reveals Safety Concerns With FDA-Approved Dual Orexin Receptor Antagonists for Insomnia

March 11th 2024

A meta-analysis on studies assessing FDA-approved dual orexin receptor antagonists for insomnia treatment highlighted a greater risk of adverse events, particularly for narcolepsy-like symptoms.

Paolo Baroldi, MD, PhD, the chief medical officer at Vanda
FDA Issues Complete Response Letter for Vanda Pharmaceuticals' Tasimelteon for Insomnia

March 11th 2024

Michael Perlis, PhD
Key Components Identified for Improving Efficacy of Cognitive Behavioral Therapy in Chronic Insomnia

February 1st 2024

Phase 3 Study Aims to Confirm Benefit of Dual Orexin–Receptor Antagonist TS-142 in Insomnia
Phase 3 Study Aims to Confirm Benefit of Dual Orexin–Receptor Antagonist TS-142 in Insomnia

April 20th 2023

Short Sleep Duration, Poor Sleep Quality Both Associated With Weight Regain in Obese Individuals
Short Sleep Duration, Poor Sleep Quality Both Associated With Weight Regain in Obese Individuals

December 17th 2022

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.